Detailed Information

Cited 172 time in webofscience Cited 211 time in scopus
Metadata Downloads

Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV

Full metadata record
DC Field Value Language
dc.contributor.authorPark, Ji-Young-
dc.contributor.authorKo, Jin-A-
dc.contributor.authorKim, Dae Wook-
dc.contributor.authorKim, Young Min-
dc.contributor.authorKwon, Hyung-Jun-
dc.contributor.authorJeong, Hyung Jae-
dc.contributor.authorKim, Cha Young-
dc.contributor.authorPark, Ki Hun-
dc.contributor.authorLee, Woo Song-
dc.contributor.authorRyu, Young Bae-
dc.date.accessioned2022-12-26T20:21:33Z-
dc.date.available2022-12-26T20:21:33Z-
dc.date.issued2016-01-02-
dc.identifier.issn1475-6366-
dc.identifier.issn1475-6374-
dc.identifier.urihttps://scholarworks.gnu.ac.kr/handle/sw.gnu/15723-
dc.description.abstractTwo viral proteases of severe acute respiratory syndrome coronavirus (SARS-CoV), a chymotrypsin-like protease (3CL(pro)) and a papain-like protease (PLpro) are attractive targets for the development of anti-SARS drugs. In this study, nine alkylated chalcones (1-9) and four coumarins (10-13) were isolated from Angelica keiskei, and the inhibitory activities of these constituents against SARS-CoV proteases (3CL(pro) and PLpro) were determined (cell-free/based). Of the isolated alkylated chalcones, chalcone 6, containing the perhydroxyl group, exhibited the most potent 3CL(pro) and PLpro inhibitory activity with IC50 values of 11.4 and 1.2 mu M. Our detailed protein-inhibitor mechanistic analysis of these species indicated that the chalcones exhibited competitive inhibition characteristics to the SARS-CoV 3CL(pro), whereas noncompetitive inhibition was observed with the SARS-CoV PLpro.-
dc.format.extent8-
dc.language영어-
dc.language.isoENG-
dc.publisherTAYLOR & FRANCIS LTD-
dc.titleChalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV-
dc.typeArticle-
dc.publisher.location영국-
dc.identifier.doi10.3109/14756366.2014.1003215-
dc.identifier.scopusid2-s2.0-84953310149-
dc.identifier.wosid000367555300003-
dc.identifier.bibliographicCitationJOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, v.31, no.1, pp 23 - 30-
dc.citation.titleJOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY-
dc.citation.volume31-
dc.citation.number1-
dc.citation.startPage23-
dc.citation.endPage30-
dc.type.docTypeArticle-
dc.description.isOpenAccessY-
dc.description.journalRegisteredClasssci-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalResearchAreaBiochemistry & Molecular Biology-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.relation.journalWebOfScienceCategoryBiochemistry & Molecular Biology-
dc.relation.journalWebOfScienceCategoryChemistry, Medicinal-
dc.subject.keywordPlusPAPAIN-LIKE PROTEASE-
dc.subject.keywordPlusRESPIRATORY SYNDROME CORONAVIRUS-
dc.subject.keywordPlus3C-LIKE PROTEASE-
dc.subject.keywordPlusMAIN PROTEINASE-
dc.subject.keywordPlusPURIFICATION-
dc.subject.keywordPlusDESIGN-
dc.subject.keywordPlusEXPRESSION-
dc.subject.keywordAuthorAngelica keiskei-
dc.subject.keywordAuthor3CL(pro)-
dc.subject.keywordAuthorchalcone-
dc.subject.keywordAuthorPLpro-
dc.subject.keywordAuthorSARS-CoV-
Files in This Item
There are no files associated with this item.
Appears in
Collections
ETC > Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE